e-learning
resources
Paris 2018
Sunday, 16.09.2018
New pharmacological strategies in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Increased type 2 inflammation in patients with asthma post rhinovirus infection
T. Southworth (Manchester, United Kingdom), C. Pattwell (Manchester, United Kingdom), S. Mowbray (Cambridge MA, United States of America), R. Strieter (Cambridge MA, United States of America), V. Erpenbeck (Basel, Switzerland), D. Singh (Manchester, United Kingdom)
Source:
International Congress 2018 – New pharmacological strategies in airway diseases
Session:
New pharmacological strategies in airway diseases
Session type:
Oral Presentation
Number:
517
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Southworth (Manchester, United Kingdom), C. Pattwell (Manchester, United Kingdom), S. Mowbray (Cambridge MA, United States of America), R. Strieter (Cambridge MA, United States of America), V. Erpenbeck (Basel, Switzerland), D. Singh (Manchester, United Kingdom). Late Breaking Abstract - Increased type 2 inflammation in patients with asthma post rhinovirus infection. 517
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Late Breaking Abstract - Effects of tezepelumab on host epithelial tolerance to virus in patients with uncontrolled asthma
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021
Late Breaking Abstract - A key endpoint in viral challenge models of asthma exacerbations
Source: International Congress 2019 – Airway physiology
Year: 2019
Vapendavir significantly improves upper respiratory symptoms of naturally acquired rhinovirus infection in asthmatic adults: Results of a phase 2 clinical trial
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013
Human rhinovirus (HRV) induced changes in mild asthma: Time course of clinical and inflammatory biomarker changes
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Late Breaking Abstract - Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021
Asthma patients hospitalized with influenza lack mucosal and systemic type 2 inflammation
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
Late Breaking Abstract - Aggravated pathology in MRSA pneumonia secondary to Influenza A virus infection diverged from decreased expression of IL-1ß
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1
Year: 2020
Late Breaking Abstract - Benralizumab treatment strongly reduces blood basophils in patients with severe eosinophilic asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Late Breaking Abstract - Systemic IL-26 correlates with improved asthma control in children with allergic sensitization
Source: International Congress 2018 – Molecular and cellular determinants of the developing lung
Year: 2018
Late Breaking Abstract - CPAP is effective in treating COVID-19 patients with Type 1 respiratory failure.
Source: Virtual Congress 2020 – Nasal high flow and non-invasive ventilation in acute and chronic care
Year: 2020
Late Breaking Abstract - Temporal relationships of cytokines, chemokines and cellular biomarkers during Human Rhinovirus (HRV) infection in asthmatics
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
Late Breaking Abstract - Exacerbation of asthma in childhood: seasonal pattern and risk factors.
Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities
Year: 2017
Late Breaking Abstract - Gender and asthma: Gender-dependent effects of obesity on allergic pulmonary inflammation
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018
Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma.
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Time course relationships of Type 1 and 2 inflammatory and innate immune pathways during Human Rhinovirus (HRV) infection in subjects with asthma
Source: International Congress 2018 – Asthma analysis
Year: 2018
Association between human rhinovirus C and severity of acute asthma in children
Source: Eur Respir J 2011; 37: 1037-1042
Year: 2011
Infection with HRV-C during acute asthma in adults is associated with increased sputum neutrophils and self-reported severity of symptoms
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Late Breaking Abstract: Persistent effect of bronchial thermoplasty (BT) in severe asthma at two years
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010
Late Breaking Abstract - Enhanced expression of IL-1ß in later stage of influenza A virus infection is independent of NLRP3 in vitro
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020
Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept